TY - JOUR
T1 - Cytotoxic Effects of Nonionic Iodinated Contrast Agent on Human Adipose-Derived Mesenchymal Stem Cells
AU - Wu, Tao
AU - Nie, Hai
AU - Dietz, Allan B.
AU - Salek, David R.
AU - Smith, Jay
AU - van Wijnen, Andre J.
AU - Qu, Wenchun
N1 - Publisher Copyright:
© 2018 American Academy of Physical Medicine and Rehabilitation
PY - 2019/1/1
Y1 - 2019/1/1
N2 - Background: Transplantation of mesenchymal stem cells (MSCs) is a promising therapy for degenerative spine conditions. However, cell therapy for painful spine degeneration presently requires use of contrast agents during fluoroscopy-guided injections, and the effects of these agents on MSCs represents a gap in knowledge. Objective: To investigate the biological effects of contrast media (CM) that are coinjected with MSCs. Design: Prospective observational study. Setting: Academic medical center. Participants: Patient-derived clinical-grade culture expanded MSCs. Interventions: Iohexol (Omnipaque300) was reduced to 12.5%, 25%, 50%, and 100% of the stock solution and incubated with MSCs for 30 minutes, 4 hours, and 48 hours. We also used complete media and 12.5%, 25%, 50%, 100% of phosphate-buffered saline as a control group. Main Outcome Measures: We examined cytotoxicity of iohexol at different concentrations and exposure duration, as well as the potential for recovery over time. Cell counts, mitochondrial activity, and quantitative real time reverse-transcriptase polymerase chain reaction of related genes were analyzed immediately after exposure (day 0) and after 2 days of exposure (day 2). Results: Human MSCs exhibit a time- and concentration-dependent cytotoxic response to iodinated CM. A brief, 30-minute exposure did not affect MSCs function and viability. However, extended treatment with iohexol for 4 hours at 50% or higher concentration had a significant impact on both viability and gene expression in MSCs. Conclusions: Iohexol is cytotoxic to MSCs in a time-and concentration-dependent manner. Hence, the concentration of CM that accompanies MSC injections should be carefully considered during MSC therapy for disk-degenerative diseases. Level of Evidence: III.
AB - Background: Transplantation of mesenchymal stem cells (MSCs) is a promising therapy for degenerative spine conditions. However, cell therapy for painful spine degeneration presently requires use of contrast agents during fluoroscopy-guided injections, and the effects of these agents on MSCs represents a gap in knowledge. Objective: To investigate the biological effects of contrast media (CM) that are coinjected with MSCs. Design: Prospective observational study. Setting: Academic medical center. Participants: Patient-derived clinical-grade culture expanded MSCs. Interventions: Iohexol (Omnipaque300) was reduced to 12.5%, 25%, 50%, and 100% of the stock solution and incubated with MSCs for 30 minutes, 4 hours, and 48 hours. We also used complete media and 12.5%, 25%, 50%, 100% of phosphate-buffered saline as a control group. Main Outcome Measures: We examined cytotoxicity of iohexol at different concentrations and exposure duration, as well as the potential for recovery over time. Cell counts, mitochondrial activity, and quantitative real time reverse-transcriptase polymerase chain reaction of related genes were analyzed immediately after exposure (day 0) and after 2 days of exposure (day 2). Results: Human MSCs exhibit a time- and concentration-dependent cytotoxic response to iodinated CM. A brief, 30-minute exposure did not affect MSCs function and viability. However, extended treatment with iohexol for 4 hours at 50% or higher concentration had a significant impact on both viability and gene expression in MSCs. Conclusions: Iohexol is cytotoxic to MSCs in a time-and concentration-dependent manner. Hence, the concentration of CM that accompanies MSC injections should be carefully considered during MSC therapy for disk-degenerative diseases. Level of Evidence: III.
UR - http://www.scopus.com/inward/record.url?scp=85059324909&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85059324909&partnerID=8YFLogxK
U2 - 10.1016/j.pmrj.2018.05.022
DO - 10.1016/j.pmrj.2018.05.022
M3 - Article
C2 - 29860023
AN - SCOPUS:85059324909
SN - 1934-1482
VL - 11
SP - 45
EP - 55
JO - PM and R
JF - PM and R
IS - 1
ER -